Institutions / Commodore Capital LP / Holdings
Back to Commodore Capital LP

Commodore Capital LP

All holdings · as of Dec 31, 2025

33 positions

CompanyClassValue ↓Shares% of portfolio
Relay Therapeutics, Inc.—$143.82M17,000,0009.6%
Alkermes plc.—$99.33M3,550,0006.6%
Tyra Biosciences, Inc.—$88.73M3,375,0005.9%
Xenon Pharmaceuticals Inc.—$80.68M1,800,0005.4%
SPYRE THERAPEUTICS, INC.—$78.24M2,388,2455.2%
Cogent Biosciences, Inc.—$78.03M2,196,8455.2%
Enliven Therapeutics, Inc.ELVNCommon Stock$72.27M4,692,8094.8%
Celldex Therapeutics, Inc.—$69.67M2,565,0004.6%
Amylyx Pharmaceuticals, Inc.—$68.25M5,650,0004.5%
Terns Pharmaceuticals, Inc.—$59.59M1,475,0004.0%
Kymera Therapeutics, Inc.—$58.36M750,0003.9%
SOLENO THERAPEUTICS, INC.—$55.56M1,200,0003.7%
Nuvalent, Inc.—$55.32M550,0003.7%
Oruka Therapeutics, Inc.—$53.14M1,753,0543.5%
Pharvaris N.V.—$52.43M1,889,4453.5%
Nurix Therapeutics, Inc.—$43.16M2,275,0002.9%
PROTAGONIST THERAPEUTICS INC—$39.30M450,0002.6%
ASSEMBLY BIOSCIENCES, INC.ASMBCommon Stock$34.01M1,000,0002.3%
LB PHARMACEUTICALS INCLBRXCommon Stock$33.39M1,500,0002.2%
CytomX Therapeutics, Inc.—$32.77M7,692,3002.2%
Alto Neuroscience, Inc.ANROCommon Stock$32.45M1,823,1962.2%
PALISADE BIO, INC.—$26.90M11,445,0001.8%
MIND MEDICINE MINDMED INC—$26.78M2,000,0001.8%
CENTESSA PHARMACEUTICALS PLC—$25.01M1,000,0001.7%
PepGen Inc.—$22.13M3,400,0001.5%
SAB Biotherapeutics, Inc.—$16.46M4,401,5001.1%
Replimune Group, Inc.—$13.85M1,425,0000.9%
Inhibikase Therapeutics, Inc.—$11.06M5,397,4880.7%
Contineum Therapeutics, Inc.—$9.33M816,3260.6%
Avalo Therapeutics, Inc.—$8.77M483,0000.6%
RAPT THERAPEUTICS INC—$8.47M250,0000.6%
LeonaBio, Inc.LONACommon Stock$3.52M464,3980.2%
BRIGHT MINDS BIOSCIENCES INC.—$1.47M18,8510.1%
← PrevPage 1 of 1Next →